pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2012-0-2-56-59pulmo-39Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL STUDIESПорахонькоН. А.PorakhonkoN. A.

научный сотрудник отдела пульмонологии и хирургических методов лечения болезней органов дыхания 

220053, Республика Беларусь, Минск, Долгиновский тракт, 157. Тел.: (375-172) 30-22-58.

nataliapora@yahoo.itЛаптеваИ. М.LaptevaI. M.

к. м. н., доцент, руководитель отдела пульмонологии и хирургических методов лечения болезней органов дыхания 

220053, Республика Беларусь, Минск, Долгиновский тракт, 157. Тел.: (375-172) 89-89-51.

irinalapteva@mail.ruГУ "РНПЦ пульмонологии и фтизиатрии МЗ Республики Беларусь"Россия201228042012025659Copyright © Порахонько Н.А., Лаптева И.М., 20122012Порахонько Н.А., Лаптева И.М.Porakhonko N.A., Lapteva I.M.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/39ReferencesChaouat A., Naeije R., Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir. J. 2008; 32: 1371–1385.Chaouat A., Naeije R., Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir. J. 2008; 32: 1371–1385.Chaouat A., Bugnet A.S., Kadaoui N. et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 172: 189–194.Chaouat A., Bugnet A.S., Kadaoui N. et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 172: 189–194.Wagner P.D. The real cause of exercise limitation in COPD. J. Appl. Physiol. 2008; 105: 75–78.Wagner P.D. The real cause of exercise limitation in COPD. J. Appl. Physiol. 2008; 105: 75–78.Pinto*Plata V.M., Celli*Cruz R.A., Vassaux C. et al. Differences in cardiopulmonary exercise tests results by American Thoracic Society / European Respiratory Societyglobal initiative for chronic obstructive pulmonary disease stage categories and gender. Chest 2007; 132: 1204–1211.Pinto*Plata V.M., Celli*Cruz R.A., Vassaux C. et al. Differences in cardiopulmonary exercise tests results by American Thoracic Society / European Respiratory Societyglobal initiative for chronic obstructive pulmonary disease stage categories and gender. Chest 2007; 132: 1204–1211.Holverda S., Bogaard H.J., Groepenhoff H. et al. Cardiopulmonary exercise tests characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension. Respiration 2008; 76: 160–167.Holverda S., Bogaard H.J., Groepenhoff H. et al. Cardiopulmonary exercise tests characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension. Respiration 2008; 76: 160–167.Kitabatake A., Inoue M., Asao M. et al. Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation 1983; 68: 302–309.Kitabatake A., Inoue M., Asao M. et al. Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation 1983; 68: 302–309.Arcasoy S.M., Christie J.D., Ferrari V.A. et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am. J. Respir. Crit. Care Med. 2003; 167: 735–740.Arcasoy S.M., Christie J.D., Ferrari V.A. et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am. J. Respir. Crit. Care Med. 2003; 167: 735–740.O'Donnell D., Webb K. Point-counterpoint: the major limitation to exercise performance in COPD is dynamic hyperinflation. J. Appl. Physiol. 2008; 105: 753–755.O'Donnell D., Webb K. Point-counterpoint: the major limitation to exercise performance in COPD is dynamic hyperinflation. J. Appl. Physiol. 2008; 105: 753–755.Debigare′ R., Maltais F. Point-counterpoint: the major limitation to exercise performance in COPD is lower limb muscle dysfunction. J. Appl. Physiol. 2008; 105: 751–753.Debigare′ R., Maltais F. Point-counterpoint: the major limitation to exercise performance in COPD is lower limb muscle dysfunction. J. Appl. Physiol. 2008; 105: 751–753.Sun X.G., Hansen E.J., Oudiz R. et al. Exercise pathophysiology inpatients with primary pulmonary hypertension. Circulation 2001; 104: 429–435.Sun X.G., Hansen E.J., Oudiz R. et al. Exercise pathophysiology inpatients with primary pulmonary hypertension. Circulation 2001; 104: 429–435.Holverda S., Rietema H., Westerhof N. et al. Stroke volume increases to exercise in COPD is limited by increased pulmonary artery pressure. Heart 2008; 95: 137–141.Holverda S., Rietema H., Westerhof N. et al. Stroke volume increases to exercise in COPD is limited by increased pulmonary artery pressure. Heart 2008; 95: 137–141.Rietema H., Holverda S., Bogaard H.J. et al. Sildenafil treatment in COPD does not affect stroke volume or exercise capacity. Eur. Respir. J. 2008; 31: 759–764.Rietema H., Holverda S., Bogaard H.J. et al. Sildenafil treatment in COPD does not affect stroke volume or exercise capacity. Eur. Respir. J. 2008; 31: 759–764.Vassaux C., Torre*Bouscoulet L., Zeineldine S. et al. Effect of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur. Respir. J. 2008; 32: 1275–1282.Vassaux C., Torre*Bouscoulet L., Zeineldine S. et al. Effect of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur. Respir. J. 2008; 32: 1275–1282.Scharf S.M., Iqbal M., Keller C. et al. Hemodynamic characterization of patients with severe emphysema. Am. J. Respir. Crit. Care Med. 2002; 166: 314–322.Scharf S.M., Iqbal M., Keller C. et al. Hemodynamic characterization of patients with severe emphysema. Am. J. Respir. Crit. Care Med. 2002; 166: 314–322.Doi M., Nakano K., Hiramoto T., Kohno N. Significance of pulmonary artery pressure in emphysema patients with mild to moderate hypoxemia. Respir. Med. 2003; 97 (8): 915–920.Doi M., Nakano K., Hiramoto T., Kohno N. Significance of pulmonary artery pressure in emphysema patients with mild to moderate hypoxemia. Respir. Med. 2003; 97 (8): 915–920.

The authors declare that there are no conflicts of interest present.